High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT03474562
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT03474562
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT03474562. Randomized; no masking; primary purpose treatment. Start 2018-04-03 (actual); primary completion 2019-06-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension
- Condition
- ASCVD
- Condition
- Impaired Fasting Glucose
- Condition
- Hypertension
- Intervention (Drug)
- Duowell®
- Intervention (Drug)
- Monorova® + Amlopin®
- Lead sponsor
- Yuhan Corporation
Record details
- Record id
cardio:ct-nct03474562- Content hash
3fa4cc5ba984cec0f59512d1bde6ab612d8f054cd4e0a881b4a2eeb8a128a3d9